16th August 2019, Volume 132 Number 1500

Joseph M Boden

At the present time there is considerable “action” concerning cannabis law and policy in New Zealand, particularly in light of upcoming changes to the availability of medicinal cannabis, and the…

Subscriber content

The full contents of this page is only available to subscribers.

To view this content please login or subscribe

Author Information

Joseph M Boden, Research Associate Professor, Director, Christchurch Health and Development Study, Department of Psychological Medicine, University of Otago, Christchurch. 


Associate Prof Joseph M Boden, Department of Psychological Medicine, University of Otago, PO Box 4345, Christchurch 8140.

Correspondence Email


Competing Interests



  1. Braithwaite I, Newton-Howes G, Oldfiel K, Semprini A. Cannabis based medicinal products and the role of the doctor: should we be cautious or cautiously optimistic? N Z Med J. 2019; 132(1500):82–88.
  2. Misuse of Drugs (Medicinal Cannabis) Amendment Act, (2018).
  3. Misuse of Drugs Act, (1975).
  4. Royal Australian College of General Practitioners. Medicinal use of cannabis products 2019 [Available from: http://www.racgp.org.au/advocacy/position-statements/view-all-position-statements/clinical-and-practice-management/medical-cannabis
  5. Caplan G. Medical marijuana: a study of unintended consequences. McGeorge Law Review. 2012; 43:127.
  6. Fergusson DM, Boden JM. Cannabis use in adolescence. In: Gluckman P, Hayne H, editors. Improving the Transition: Reducing Social and Psychological Morbidity During Adolescence: Office of the Prime Minister’s Science Advisory Committee; 2011. p. 257–71.
  7. Wells JE, McGee MA, Baxter J, Agnew F, Kokaua J. Onset and lifetime use of drugs in New Zealand: Results from Te Rau Hinengaro: The New Zealand Mental Health Survey 2003–2004. Drug Alcohol Rev. 2009; 28(2):166–74.
  8. Ball J, Sim D, Edwards R, Fleming T, Denny S, Cook H, et al. Declining adolescent cannabis use occurred across all demographic groups and was accompanied by declining use of other psychoactive drugs, New Zealand, 2001–2012. N Z Med J. 2019; 132(1500):12–24.
  9. Kuntsche E, Simons-Morton B, Fotiou A, ter Bogt T, Kokkevi A, Health Behavior in School-Aged Children S. Decrease in adolescent cannabis use from 2002 to 2006 and links to evenings out with friends in 31 European and North American countries and regions. Arch Pediatr Adolesc Med. 2009; 163(2):119–25.
  10. De Looze M, van Dorsselaer S, Stevens GWJM, Boniel-Nissim M, Vieno A, Van den Eijnden RJJM. The decline in adolescent substance use across Europe and North America in the early twenty-first century: A result of the digital revolution? Int J Public Health. 2019; 64(2):229–40.
  11. Babor T, Caetano R, Casswell S, Edwards G, Giesbrecht N, Graham K, et al. Alcohol: No ordinary commodity. Second ed. Oxford: Oxford University Press; 2010.
  12. New Zealand Herald. Cannabis referendum pass results decline but tracking to pass, according to new poll Auckland: New Zealand Herald; 2019 [Available from: http://www.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=12229060


The downloadable PDF version of this article is only available to subscribers.

To view this content please login or subscribe